Join us for a Special Meetup: Managing the Emotions of MBC at a Young Age - Jan 29, 2025 at 1pm ET Register here.
Join our Webinar: REAL Talk: Healthy Body and Mind After Breast Cancer Treatment - Jan 23, 2025 at 4pm ET Register here.
FDA Approves Enhertu for Unresectable or Metastatic HER2-Low BC
moderators
Posts: 8,797
FDA Approves Enhertu for Unresectable or Metastatic HER2-Low Breast Cancer
Aug 5, 2022
On Aug. 5, 2022, the U.S. Food and Drug Administration approved Enhertu to treat unresectable or metastatic HER2-low breast cancer. Read more...
0
Categories
Join Us on Zoom: Upcoming virtual meetups. Read more...
Give your account some personality! Add a profile photo.